Zhili Xu Selected Research

2- ((1H- benzo(d)(1,2,3)triazol- 5- ylamino)methyl)- 4,6- dichlorophenol

5/2016	Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors.
10/2015	Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhili Xu Research Topics

Disease

6	Neoplasms (Cancer) 01/2019 - 04/2008
5	Hyperalgesia 01/2022 - 10/2015
5	Pain (Aches) 11/2019 - 10/2015
3	Neuralgia (Stump Neuralgia) 01/2019 - 12/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
2	Migraine Disorders (Migraine) 05/2021 - 11/2019
2	Hepatocellular Carcinoma (Hepatoma) 04/2008 - 01/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Acute Pain 05/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Hypersensitivity (Allergy) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Heart Failure 05/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Synovitis 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Constipation 11/2017
1	Diarrhea 07/2017
1	Cognitive Dysfunction 05/2016
1	Chronic Pain 10/2015
1	Shock 03/2010
1	Thrombocytopenia (Thrombopenia) 03/2010

Drug/Important Bio-Agent (IBA)

6	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 10/2015
3	CannabinoidsIBA 01/2019 - 12/2016
2	CB2 Cannabinoid ReceptorIBA 01/2022 - 12/2016
2	Liposomes (Liposome)IBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 11/2019 - 01/2019
2	EndocannabinoidsIBA 01/2019 - 12/2016
2	Freund's AdjuvantIBA 11/2018 - 10/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 10/2015
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2018 - 10/2015
2	CytokinesIBA 01/2018 - 03/2010
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 10/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2015
2	Formaldehyde (Formol)FDA Link 01/2018 - 10/2015
2	2- ((1H- benzo(d)(1,2,3)triazol- 5- ylamino)methyl)- 4,6- dichlorophenolIBA 05/2016 - 10/2015
1	enhanced green fluorescent proteinIBA 01/2022
1	3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA 01/2022
1	CB2 receptor agonist LY2828360IBA 01/2022
1	Memantine (Namenda)FDA Link 05/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Inhibins (Inhibin)IBA 01/2020
1	ClaudinsIBA 01/2020
1	Pain-FreeIBA 11/2019
1	dexketoprofen trometamol (Keral)IBA 11/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	schizandrin AIBA 01/2019
1	anandamide (arachidonylethanolamide)IBA 01/2019
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2019
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2019
1	URB937IBA 01/2019
1	AmidesIBA 01/2019
1	AntidiarrhealsIBA 01/2019
1	EnzymesIBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Cannabinoid Receptor AgonistsIBA 01/2019
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2018
1	3- (2- nitro- 1- phenylethyl)- 2- phenyl- 1H- indoleIBA 11/2018
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	ChemokinesIBA 01/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2018
1	N-end cysteine peptide tumor-homing peptideIBA 01/2018
1	InterleukinsIBA 01/2018
1	ardipusilloside IIBA 11/2017
1	isoquinolineIBA 07/2017
1	AlkaloidsIBA 07/2017
1	BerberineIBA 07/2017
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 12/2016
1	Opioid Analgesics (Opioids)IBA 12/2016
1	Analgesics (Analgesic Drugs)IBA 12/2016
1	Desipramine (Pertofrane)FDA LinkGeneric 12/2016
1	Dizocilpine Maleate (Dizocilpine)IBA 10/2015
1	LipidsIBA 03/2010
1	Platelet Activating FactorIBA 03/2010
1	Conditioned Culture MediaIBA 04/2008
1	hepatitis B virus X proteinIBA 01/2008

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Therapeutics 01/2020 - 04/2017
1	Immunotherapy 01/2022
1	Palliative Care (Palliative Therapy) 05/2018
1	Cystectomy 05/2018
1	Subcutaneous Infusions 12/2016
1	Splenectomy 03/2010
1	Intravenous Injections 03/2010
1	Transplantation 04/2008